ARDX insider trading
NasdaqGM HealthcareARDELYX, INC.: insider trade history from SEC Form 4 filings.
About ARDELYX, INC.
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Company website: www.ardelyx.com
ARDX insider activity at a glance
FilingIQ tracks 884 insider transactions for ARDX in filings since Jan 2, 2015. The most recent transaction is dated Aug 21, 2026.
Across the full history, 106 open-market purchases
and 460 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ARDX insider trades is 52.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ARDX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ARDX?
- FilingIQ tracks 884 Form 4 insider transactions for ARDX (ARDELYX, INC.), covering filings from Jan 2, 2015 onwards. 23 of those are dated within the last 90 days.
- Are ARDX insiders net buyers or net sellers?
- Across the full Form 4 history for ARDX, 106 transactions (12%) were open-market purchases and 460 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ARDX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is ARDX in?
- ARDELYX, INC. (ARDX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.50B.
Methodology & sources
Every ARDX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.